Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...] …
Category: State
Novartis is now the third drug manufacturer to challenge Kansas’ new law prohibiting drug manufacturers from restricting contract pharmacy access [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
A powerful drug industry trade group has asked the U.S. Supreme Court to overturn a federal appeals court’s decision to [...] …
An industry-funded conservative policy group known for delivering model bills to Republican lawmakers recently urged an audience of state legislators [...] …
After six months of heated battles in the states to restore access to 340B drug discounts in the contract pharmacy [...] …
A well-known candidate in a tightly contested Missouri Republican gubernatorial primary has called to “repeal 340B in Missouri” after the [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Pharmaceutical giant AbbVie yesterday became the first drugmaker to file suit against Missouri’s new law prohibiting 340B contract pharmacy restrictions [...] …
Merck will loosen its 340B contract pharmacy restrictions in Minnesota and Missouri, becoming the first drugmaker to officially update its [...] …